Frugal by design.
Accessible by cost.
Sovereign by industry.
Today, caring for tomorrow
InViDiX develops paper-based rapid diagnostic tests that replace plastic with patented sustainable materials — reducing waste by 90% and cutting costs up to 50%, while enabling local manufacturing worldwide.
Measurable Impact
Our innovative approach to diagnostic testing delivers tangible improvements across cost, sustainability, and production capacity.
The Hidden Structural Cost of Conventional Diagnostics
Conventional rapid tests are 95% plastic. They are imported, bulky, and difficult to dispose of. Each year, billions of tests generate unnecessary material waste, inflate logistics and disposal costs, and lock health systems into fragile, import-dependent supply chains.
This creates significant challenges for healthcare systems worldwide: increased environmental impact, higher operational costs, supply chain vulnerabilities, and limited local manufacturing capabilities.
The issue is not performance, it is industrial design.
InViDiX addresses the root cause by reimagining the fundamental structure of rapid diagnostic tests.
Patented Paper-Based Innovation
InViDiX replaces plastic with patented paper resistant to water, urine, and blood, delivering the same diagnostic performance with dramatically reduced environmental impact.
Material Frugality as Standard
Paper replaces plastic at the core of the product, reducing waste and end-of-life constraints by design. Our platform applies across reproductive health, infectious diseases, and STI diagnostics.
Designed for Local Manufacturing
Built for technology transfer and local assembly, reducing import dependency and restoring health system autonomy. Empowering local production capabilities worldwide.
Crisis-Ready by Design
Innovative scalable production (>1M tests/month) enables rapid response to epidemics and emergencies. Prepared for the unexpected with flexible manufacturing capacity.
Comprehensive Diagnostic Solutions
Our paper-based platform supports a wide range of diagnostic applications across multiple health domains.
Fertility & Reproductive Health
Sexually Transmitted Infections (STIs)
Tropical & Infectious Diseases
InViDiX vs Conventional Tests
Same diagnostic purpose, lower structural cost. See how our innovation compares to traditional plastic-based tests.
Conventional Pregnancy Test
InViDiX Pregnancy Test
How We Deliver Value
Our approach combines material innovation, manufacturing flexibility, and scalable production to create a sustainable diagnostic testing ecosystem.
Cost Efficiency
Paper is inherently cheaper and lighter than injection-moulded plastic, cutting raw-material and shipping costs to deliver up to 50% lower unit price with no trade-off in diagnostic accuracy.
Sustainability
A single InViDiX test weighs just 1 g versus 10 g for a conventional cassette. Because the housing is biodegradable paper, disposal is simpler and total material waste drops by a factor of ten.
Supply Chain Resilience
Our design requires only standard paper-converting equipment, enabling technology transfer and local assembly in-country — freeing health systems from long, fragile import pipelines.
Who We Are
Transform Rapid Diagnostics
We make rapid diagnostics frugal, accessible, and sovereign — turning disposable plastic objects into a sustainable industrial standard that any country can produce locally.
Redesign Global Foundations
We envision a world where every health system can manufacture its own high-performance diagnostic tests from sustainable materials, independent of fragile global supply chains.
InViDiX is a diagnostic company present in 10+ countries, focused on redesigning rapid tests as industrial systems rather than disposable objects. We believe that sustainable healthcare begins with reimagining the fundamental structure of medical devices.
Let's Transform Healthcare Together
Contact our team to learn more about InViDiX technology, partnership opportunities, and how we can build a more sustainable diagnostic future.
Contact Our Team